MEREO BIOPHARMA GROUP PLC Key Management Personnel Compensation Shortterm Employee Benefits
MEREO BIOPHARMA GROUP PLC (MREO) reported Key Management Personnel Compensation Shortterm Employee Benefits of GBP 3.70 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-28.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits · last filed 2023-03-28
| Period end | Key Management Personnel Compensation Shortterm Employee Benefits 12 month | Key Management Personnel Compensation Shortterm Employee Benefits 12 month as first filed |
|---|---|---|
| 2022-12-31 | 3.70M GBP 20-F · filed 2023-03-28 | |
| 2021-12-31 | 4.02M GBP 20-F · filed 2023-03-28 | |
| 2020-12-31 | 4.48M GBP 20-F · filed 2023-03-28 | |
| 2019-12-31 | 3.49M GBP 20-F · filed 2022-03-31 | |
| 2018-12-31 | 3.18M GBP 20-F · filed 2021-03-31 | 3.18M GBP 20-F/A · filed 2019-05-29 |
| 2017-12-31 | 2.76M GBP 20-F · filed 2020-06-15 | 2.76M GBP 20-F/A · filed 2019-05-29 |
| 2016-12-31 | 2.11M GBP 20-F/A · filed 2019-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |